influenza trivalent vaccine (split virion inactivated)
Influenza vaccine trivalent (split virion, inactivated)
Product Details
WHO Product ID
FVP-P-312
Status
Prequalified
Date of prequalification
Vaccine type
Influenza vaccine trivalent (split virion, inactivated)
Abbreviated Name
IIV3
Commercial Name
influenza trivalent vaccine (split virion inactivated)
PQ Holder
Instituto Butantan
Av. Vital Brazil 1500
São Paulo,
05503-900
Brazil
Responsible NRA
Agencia Nacional da Vigilancia Sanitaria (ANVISA)
Product description
Pharmaceutical Form
Liquid: Ready to use
Presentation
Vial
Number of doses
10
Route of administration
Intramuscular or deep subcutaneous
Vaccine Vial Monitor
Type 7
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be used in subsequent immunization sessions (up to 28 days) if the conditions outlined in the WHO Policy Statement are met.
Shelf life (months)
12 months
Storage temperature
2 - 8°C
Diluent
N/A
Preservative
Thiomersal
Preservative concentration
2 ?g/dose
Product Packaging
Secondary Container
Tertiary Container
Component Packed
Active (Vaccine)
Total doses
20
Description
Carton box containing 20 vials of 10 doses (0.5 mL per dose) [Dimensions: 13.5 x 11.0 x 5.5 cm]
Dimensions
13.5 x 11.0 x 5.5 cm
Cold Chain Volume (cm³/dose)
4.08